ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
Drug that increases sex drive in women
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 10723" data-attributes="member: 3"><p>[ATTACH]990[/ATTACH]</p><p><img src="https://journals.prous.com/journals/common/vspacer.gif" class="bbImage" alt="" data-url="https://journals.prous.com/journals/common/vspacer.gif" style="" /><img src="https://journals.prous.com/journals/common/vspacer.gif" class="bbImage" alt="" data-url="https://journals.prous.com/journals/common/vspacer.gif" style="" /><img src="https://journals.prous.com/journals/common/vspacer.gif" class="bbImage" alt="" data-url="https://journals.prous.com/journals/common/vspacer.gif" style="" /><img src="https://journals.prous.com/journals/common/vspacer.gif" class="bbImage" alt="" data-url="https://journals.prous.com/journals/common/vspacer.gif" style="" /></p><table class='post-table width: 100%' style='width: 100%'><tr><td ><p>Drugs Today 2014, 50(8): 549</p></td><td ><p>[TD="width: 238"]</p></td><td></td><td ><p>[/TD]</p></td></tr><tr><td ><p>[TD="colspan: 2"]</p></td><td></td><td ><p>[/TD]</p></td></tr><tr><td ><p><strong>Flibanserin for female sexual dysfunction</strong><br /> <em>Reviriego, C.</em></p></td><td ><p>[TD="width: 238"]</p></td><td></td><td ><p>[/TD]</p></td></tr><tr><td ><p>[TD="colspan: 2"]</p></td><td></td><td ><p>[/TD]</p></td></tr><tr><td ><table class='post-table width: 450' style='width: 100%'><tr><td ><p>[TD="class: normal, bgcolor: #FFFFFF"]Hypoactive sexual desire disorder (HSDD) is the most commonly described form of female sexual dysfunction. There is currently no pharmacological therapy approved to treat HSDD, and therefore, there is an unmet medical need for the development of efficacious treatment alternatives. Flibanserin is a novel, non-hormonal drug for the treatment of HSDD in pre- and postmenopausal women, although the application submitted to the U.S. Food and Drug Administration by Sprout Pharmaceuticals is only for premenopausal women. Flibanserin works by correcting an imbalance of the levels of the neurotransmitters that affect sexual desire. More specifically, flibanserin increases dopamine and norepinephrine, both responsible for sexual excitement, and decreases serotonin, responsible for sexual inhibition. Clinically, flibanserin has exhibited some encouraging results in terms of its ability to increase the frequency of satisfying sexual events, and the intensity of sexual desire. However, adverse events such as dizziness, nausea, fatigue and somnolence, typical of a centrally acting drug, are also frequently related to flibanserin treatment.</p></td></tr></table></p></td><td></td><td ><p>[/TD]</p></td></tr></table></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 10723, member: 3"] [ATTACH alt="4633584_G copy.jpg"]990[/ATTACH] [IMG]https://journals.prous.com/journals/common/vspacer.gif[/IMG][IMG]https://journals.prous.com/journals/common/vspacer.gif[/IMG][IMG]https://journals.prous.com/journals/common/vspacer.gif[/IMG][IMG]https://journals.prous.com/journals/common/vspacer.gif[/IMG] [TABLE=width:-100%][TR][TD] Drugs Today 2014, 50(8): 549 [/TD] [TD] [TD="width: 238"] [/TD] [TD] [/TD] [/TD][/TR] [TR][TD] [TD="colspan: 2"] [/TD] [TD] [/TD] [/TD][/TR] [TR][TD] [B]Flibanserin for female sexual dysfunction[/B] [I]Reviriego, C.[/I] [/TD] [TD] [TD="width: 238"] [/TD] [TD] [/TD] [/TD][/TR] [TR][TD] [TD="colspan: 2"] [/TD] [TD] [/TD] [/TD][/TR] [TR][TD] [TABLE=width:-450][TR][TD] [TD="class: normal, bgcolor: #FFFFFF"]Hypoactive sexual desire disorder (HSDD) is the most commonly described form of female sexual dysfunction. There is currently no pharmacological therapy approved to treat HSDD, and therefore, there is an unmet medical need for the development of efficacious treatment alternatives. Flibanserin is a novel, non-hormonal drug for the treatment of HSDD in pre- and postmenopausal women, although the application submitted to the U.S. Food and Drug Administration by Sprout Pharmaceuticals is only for premenopausal women. Flibanserin works by correcting an imbalance of the levels of the neurotransmitters that affect sexual desire. More specifically, flibanserin increases dopamine and norepinephrine, both responsible for sexual excitement, and decreases serotonin, responsible for sexual inhibition. Clinically, flibanserin has exhibited some encouraging results in terms of its ability to increase the frequency of satisfying sexual events, and the intensity of sexual desire. However, adverse events such as dizziness, nausea, fatigue and somnolence, typical of a centrally acting drug, are also frequently related to flibanserin treatment. [/TD][/TR][/TABLE] [/TD] [TD] [/TD] [/TD][/TR][/TABLE] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
Drug that increases sex drive in women
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top